Source: Wealth Investment Network

The field of synthetic biology ushered in a heavy positive event catalysis, A- share synthetic biology concept continued to stage a tide of ups and downs. Market analysis, the recent A- share synthetic biological field of leading enterprises Kaisai Bio (688065) main business products for long-chain dibasic acid, then the relevant sectors or usher in the opportunity to make up. Public information shows that Jiangsu reached Biotechnology Co., Ltd., a wholly-owned subsidiary of Pingtan Development (000592), has made long-chain dibasic acid products through biological fermentation and is involved in the concept of synthetic biology.

As the first trading day after May Day, the-share market was booming on Monday, especially the synthetic biology concept, which took over the strength before May Day and continued to stage a daily limit today. Judging from the rise list, the share price of Azure Biology (603739), the leader of the synthetic biological concept, has been trading for four consecutive trading days, while Shengda Biology (603079), a popular variety of synthetic biological concept, has recorded three trading days in the past four trading days, the stock prices of Luhong Pharmaceutical (600789), Chuanning Biology (301301), Fuji Lai (301258) and Bon Group (001366), these synthetic biological concept stocks, have also been closed for two consecutive trading days, synthetic biology concept stocks whose stock prices closed today also include Xinghu Technology (600866), Haofan Biology (301393), Jindan Technology (300829), Sobao Protein (603231), Guangji Pharmaceutical (000952), Freda (600223), Tibet Pharmaceutical (600211), Dinglong Technology (603004), etc. In addition, the two synthetic biological concept stocks of Verdoli (300381) and Kaiser Bio (688065) have increased by 79% and 32% respectively in the past four trading days.

Combined with the news, according to the latest reports of relevant media on May 5, the team of the Future Food Science Center of Jiangnan University used synthetic biology technology to produce hyaluronic acid with ordinary molecular weight by microbial fermentation, reducing the cost from tens of thousands of yuan per kilogram to several hundred yuan per kilogram, thus realizing the popularization and application of large-scale production of hyaluronic acid. It can be seen that under the background that the news in the field of synthetic biology has ushered in such a heavy positive event, the concept stocks of synthetic biology in the-share market continue to stage a daily limit. Market analysts said that under the catalytic effect of heavy positive events, synthetic biological concept stocks are expected to replace the low-altitude economic concept and become the hottest hot outlet in the current A- share market! So, how to tap the new potential dark horse varieties of synthetic biological concept stocks? Public information shows that Jiangsu Dacheng Biotechnology Co., Ltd., a wholly-owned subsidiary of Pingtan Development (000592), is involved in the field of synthetic biological concepts by producing long-chain dibasic acid products through biological fermentation.

the field of synthetic biology ushered in heavy positive event catalysis

Synthetic biology concept stocks in the-share market continue to stage a daily limit. Synthetic biology concept stocks may have replaced the low-altitude economic concept and become the hottest hot outlet in the current A- share market.

On the news, according to the latest media reports on May 5, it is reported that the team of the Future Food Science Center of Jiangnan University uses synthetic biology technology to produce hyaluronic acid of ordinary molecular weight with the help of microbial fermentation, reducing the cost from tens of thousands of yuan per kilogram to several hundred yuan per kilogram, thus realizing the popularization and application of large-scale production of hyaluronic acid. Through artificial synthesis, the team redesigned and modified existing, naturally occurring biological systems, and even created "biological structures" that do not exist in nature, greatly increasing production. With the efforts of the synthetic biology innovation team of the Future Food Science Center of Jiangnan University, my country has become the first country capable of producing all types of hyaluronic acid.

hyaluronic acid, also known as hyaluronic acid, is widely found in the human body, with lubricating joints and more important skin moisturizing function. In this technical research, the use of cell factories to produce "everything" has greatly reduced the cost of raw materials, so that the acquisition of many cosmetic raw materials no longer depends on traditional animal and plant extraction.

Synthetic biology (Synthetic Biology) is an interdisciplinary field that combines knowledge and techniques from multiple disciplines such as biology, engineering, computer science, molecular biology, and genetics. The goal of synthetic biology is to design and build new biological components (such as enzymes, genetic circuits, and organelles), biological systems (such as microorganisms or cell factories), and even fully artificial biological entities to achieve specific functions and purposes. Developments in this field date back to the 1970 s, but significant progress was not made until the early 2000 s.

Synthetic biology, in easy-to-understand terms, is the study of synthetic biological methods to recombine and modify existing biological genes in nature to create organisms with specific functions. Because of the leap from "knowing life" to "designing life", synthetic biology is also considered as the third biotechnology revolution.

Market participants said that the recent breakthrough in the field of synthetic biotechnology announced by Xian Jiangnan University is undoubtedly a catalyst for the continued market of synthetic biological concept stocks in the-share market.

In fact, synthetic biology, which seems to be a very high field, is being highly valued by our country. Both the state and the local government are successively introducing a series of relevant policies to cheer up the industry.

In fact, as early as more than a year ago, the "14th Five-Year Plan for Bioeconomic Development" issued by the state emphasized the importance of synthetic biology in black and white. It is not only required to accelerate the development of high-throughput gene sequencing technology, but also to promote technological innovation in synthetic biology.

Not only at the central level, but also in many provinces and cities across the country. Taking Shanghai as an example, it has introduced an action plan for synthetic biological innovation, with the goal of creating a high-end biological manufacturing industry cluster. Other provinces and cities are also a variety of synthetic biological industrial clusters, industrial clusters, industrial innovation highlands.

It is reported that, led by the National Development and Reform Commission, the Ministry of Industry and Information Technology and the Ministry of Science and Technology are jointly developing a national biotechnology and biomanufacturing action plan, and it is expected to be released in the near future, "biomanufacturing" is the key content.

According to statistics, the number of papers published in the field of synthetic biology in China has ranked second in the world, accounting for 10.61 per cent of the total number of papers in the world. Synthetic biology research in my country is developing continuously from the industrial field to the fields of agriculture, medicine, health and environment, showing a rapid development trend in many fields.

Looking to the future, the latest research report of Pacific Securities pointed out that synthetic organisms are based on genetic engineering and have many advantages in energy saving, emission reduction, efficiency improvement and raw material regeneration. With the rapid progress of computing, bioinformatics and artificial intelligence, the development of synthetic biology has entered the "fast lane". According to McKinsey estimates, synthetic biology will have a $2 trillion -4 trillion economic impact on materials, chemicals and energy, human health and performance, agriculture, aquaculture and food, consumer goods and services.

under the background that the news in the field of synthetic biology is catalyzed by heavy positive events, the concept stocks of synthetic biology in the-share market on Monday will continue to stage a crazy rally after taking over the strength before may day! Judging from the rise list, the share price of Azure Biology (603739), the leader of the synthetic biological concept, has been trading for four consecutive trading days, while Shengda Biology (603079), a popular variety of synthetic biological concept, has recorded three trading days in the past four trading days, the stock prices of Luhong Pharmaceutical (600789), Chuanning Biology (301301), Fuji Lai (301258) and Bon Group (001366), these synthetic biological concept stocks, have also been closed for two consecutive trading days, synthetic biology concept stocks whose stock prices closed today also include Xinghu Technology (600866), Haofan Biology (301393), Jindan Technology (300829), Sobao Protein (603231), Guangji Pharmaceutical (000952), Freda (600223), Tibet Pharmaceutical (600211), Dinglong Technology (603004), etc. In addition, the two synthetic biological concept stocks of Verdoli (300381) and Kaiser Bio (688065) have increased by 79% and 32% respectively in the past four trading days.

Various signs show that under the catalytic effect of heavy positive events, synthetic biological concept stocks are expected to replace the low-altitude economic concept and become the hottest hot outlet in the current A- share market! So, how to tap the new potential of synthetic biological concept stocks dark horse varieties? Looking around the Shanghai and Shenzhen A- share markets, low-priced small market capitalization of authentic synthetic biological concept stocks is undoubtedly worthy of focus.

The main product of Pingtan Development's wholly-owned subsidiary is a successful commercial product of synthetic biology.

It is reported that the main business product of Kaisai Biology (688065), a leading enterprise in the field of synthetic biology, is long-chain dibasic acid. And Pingtan Development (000592) wholly-owned subsidiary-Jiangsu reached Biotechnology Co., Ltd. is mainly engaged in the research and development, production and sales of long-chain dibasic acid. Long chain dibasic acid, also known as long carbon chain dibasic acid, refers to the straight carbon chain aromatic saturated dicarboxylic acid containing 10 or more carbon atoms, is an important fine chemical intermediates, can be synthesized spices, special nylon, polyamide hot melt adhesive and other special chemicals. Long-chain dibasic acid is one of the successful commercial products of synthetic biology, that is to say, bio-based long-chain dibasic acid is a very authentic synthetic biological product! The main business product of Kaisai Bio (688065), a leading enterprise in the field of synthetic biology, is long-chain dibasic acid! Then, Jiangsu Dacheng Biotechnology Co., Ltd., a wholly-owned subsidiary of Pingtan Development (000592), produces long-chain dibasic acid products through biological fermentation, which indicates that Pingtan Development (000592) may be involved in the field of synthetic biology.

As a wholly-owned subsidiary of Pingtan Development (000592), Jiangsu Danda Biotechnology Co., Ltd. is located in Nantong Economic and Technological Development Zone. It is a multi-patent, high-tech, high-standard private company with biological fermentation as the core technology. Enterprise, mainly engaged in the research and development, production and sales of long-chain dibasic acid. The company has a high-quality, experienced management team and expert-level scientific research personnel, and has an engineering technology center, a long-chain dibasic acid product industrialization research and development laboratory, follow-up and downstream product development and research, forming a long-chain dibasic acid as the core of the industrial chain.

According to the official website of Jiangsu Danda Biotechnology Co., Ltd., the company adheres to the corporate tenet of "leading high-end technology and facing the global market", innovates development models, promotes sustainable development to the greatest extent, and builds into a world-class dibasic acid production enterprise.

Public informationAccording to the report, Pingtan Development (000592) said on the investor interaction platform on August 10, 2022 that the company's wholly-owned subsidiary, Reach Bio, produced long-chain dibasic acid products through biological fermentation, which is an important fine chemical intermediate and can synthesize special chemicals such as spices, special nylon and polyamide hot melt adhesives.

Sina statement: This news is reprinted from Sina's cooperative media. Sina posted this article for the purpose of conveying more information, and does not mean that it agrees with its views or confirms its description. The content of the article is for reference only and does not constitute investment advice. Investors operate accordingly at their own risk.